Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 1
2006 5
2007 7
2008 7
2009 2
2010 7
2011 4
2012 3
2013 5
2014 2
2015 2
2016 1
2017 1
2018 1
2019 3
2020 4
2021 6
2022 10
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Results by year

Filters applied: . Clear all
Page 1
Prognostic factors for COVID-19 patients.
Önal U, Aydın Güçlü Ö, Akalın H, Aylin Acet Öztürk N, Semet C, Demirdöğen E, Görek Dilektaşlı A, Sağlık İ, Kazak E, Özkaya G, Coşkun F, Ediger D, Heper Y, Ursavaş A, Yılmaz E, Uzaslan E, Karadağ M. Önal U, et al. Among authors: ursavas a. J Infect Dev Ctries. 2022 Mar 31;16(3):409-417. doi: 10.3855/jidc.15845. J Infect Dev Ctries. 2022. PMID: 35404844 Free article.
Tocilizumab treatment in COVID-19: A prognostic study using propensity score matching.
Güçlü ÖA, Önal U, Akalın H, Öztürk NAA, Belik HÖ, Demirdöğen E, Dilektaşlı AG, Kazak E, Ocakoğlu G, Sağlık İ, Coşkun F, Ediger D, Heper Y, Ursavaş A, Yılmaz E, Uzaslan E, Karadağ M. Güçlü ÖA, et al. Among authors: ursavas a. Adv Clin Exp Med. 2022 Nov;31(11):1197-1206. doi: 10.17219/acem/151912. Adv Clin Exp Med. 2022. PMID: 35951629 Free article.
Development and validation of a simple risk scoring system for a COVID-19 diagnostic prediction mode.
Aydın Güçlü Ö, Ursavaş A, Ocakoğlu G, Demirdöğen E, Acet Öztürk NA, Ömer Topçu D, Terzi OE, Önal U, Görek Dilektaşlı A, Sağlık İ, Coşkun F, Ediger D, Uzaslan E, Akalın H, Karadağ M. Aydın Güçlü Ö, et al. Among authors: ursavas a. Tuberk Toraks. 2023 Dec;71(4):325-334. doi: 10.5578/tt.20239601. Tuberk Toraks. 2023. PMID: 38152003 Free article. English.
Serum Krebs von den Lungen-6: promising biomarker to differentiate CPFE from IPF.
Demirdöğen E, Görek Dilektaşlı A, Acet Öztürk NA, Yeşilbursa D, Budak F, Coşkun F, Öztürk A, Ursavaş A, Özkaya G, Karadağ M, Uzaslan E. Demirdöğen E, et al. Among authors: ursavas a. Sarcoidosis Vasc Diffuse Lung Dis. 2022 Dec 19;39(4):e2022035. doi: 10.36141/svdld.v39i4.11344. Sarcoidosis Vasc Diffuse Lung Dis. 2022. PMID: 36533605 Free PMC article.
Interleukin-21: a potential biomarker for diagnosis and predicting prognosis in COVID-19 patients.
Acet Öztürk NA, Ursavaş A, Dilektaşlı AG, Demirdöğen E, Coşkun NF, Ediger D, Uzaslan AE, Yöyen Ermiş D, Karaca M, Terzi OE, Bayram M, Ömer Topçu D, Yiğitliler B, Yurttaş A, Maharramov S, Yazıcı G, Oral HB, Karadağ M. Acet Öztürk NA, et al. Among authors: ursavas a. Turk J Med Sci. 2021 Oct 21;51(5):2274-2284. doi: 10.3906/sag-2102-24. Turk J Med Sci. 2021. PMID: 34174793 Free article.
Serum CCL-18 level is a risk factor for COPD exacerbations requiring hospitalization.
Dilektasli AG, Demirdogen Cetinoglu E, Uzaslan E, Budak F, Coskun F, Ursavas A, Ercan I, Ege E. Dilektasli AG, et al. Among authors: ursavas a. Int J Chron Obstruct Pulmon Dis. 2017 Jan 5;12:199-208. doi: 10.2147/COPD.S118424. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 28115842 Free PMC article.
70 results